NCI-CPTC
NCI's CPTAC Releases Proteogenomic Data, Methods for Pan-Cancer Analysis
Researchers from the National Institutes of Health have generated standardized genomic, proteomic, imaging, and clinical data from across 10 cancer types.
NCI's Plan for Clinical Proteomics Initiative Spurs Questions about Sourcing of Patient Samples
Premium
In particular, George Mason University researcher Emanuel Petricoin expressed concerns about the project's plan to use samples from different patient cohorts for its discovery and verification stages.
The project is part of the CPTC's Antibody Characterization Program, which aims to thoroughly characterize all monoclonal antibodies used in the initiative in an effort to minimize the experimental variability that has often hampered the use of affinity reagents in proteomics research.
The alliance aims to take proteomics into the clinical chemistry lab and to encourage proteomics researchers to adopt procedures and processes that are routinely practiced in clinical chemistry labs.